Carroucell

Carroucell is a private, Paris-based biotech firm developing innovative microcarrier technology to address scalability and cost challenges in cell and gene therapy manufacturing. Its core innovation, FlexiGrow, is a bioactive glass microcarrier derived from a reinvented sol-gel process, offering superior cell adhesion, recovery, and consistency for static culture systems. The company positions itself as a critical enabler for the industrial-scale production of advanced therapies, targeting both research laboratories and the biopharmaceutical industry. While currently in a pre-revenue or early-revenue stage, Carroucell has garnered institutional recognition and partnerships to validate its platform.

Proprietary sol-gel technology for manufacturing bioactive glass microcarriers (FlexiGrow) designed for scalable, high-yield adherent cell culture in static systems.

Carroucell competes in the microcarrier market dominated by large life science tools companies like Corning and Thermo Fisher Scientific. Its differentiation lies in the unique material properties (sol-gel derived bioactive glass), flat disc shape, and claims of 100% cell recovery, specifically targeting the static culture niche for cell therapy scale-up.